Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative in Puerto Rico
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Puerto Rico
| Provider | Medicare | Services |
|---|---|---|
| Cmt Group, Corp | $22.67 | 14 |
Puerto Rico Pricing in Context
In Puerto Rico, CPT code 86328 (Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative) carries an average Medicare payment of $25.24 — 43% below the national benchmark of $44.34. 9 providers across the state submitted claims for this procedure in 2023, performing 32 total services. Individual payments in PR ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Puerto Rico is $26.84, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Puerto Rico sits below the national Medicare average, commercial rates in the state may also run lower than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in Puerto Rico lands near $56.54, with self-pay cash prices typically around $26.31. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative cost in Puerto Rico?
The average Medicare payment for Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative in Puerto Rico is $25.24, which is 43% below the national average of $44.34. Providers in PR typically bill $26.84 for this procedure.
What does Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative cost with insurance in Puerto Rico?
With commercial insurance in Puerto Rico, Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative costs an estimated $56.54. Without insurance, the estimated cash price is $26.31. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative in Puerto Rico?
9 providers in Puerto Rico billed Medicare for Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative in 2023, performing 32 total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative cheaper in Puerto Rico than the national average?
Yes — Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative costs 43% below the national average in Puerto Rico. The state average Medicare payment is $25.24 compared to $44.34 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.